Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation: A systematic review.
Filippo SanfilippoJessica Marika CurròLuigi La ViaVeronica DezioGennaro MartucciSerena BrancatiPaolo MurabitoFederico PappalardoMarinella AstutoPublished in: Artificial organs (2022)
Anticoagulation with NM in ECMO has not been prospectively studied. While several centers have experience with this approach in high-risk patients, prospective studies are warranted to establish the optimal space of this approach in ECMO.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- respiratory failure
- end stage renal disease
- atrial fibrillation
- venous thromboembolism
- newly diagnosed
- ejection fraction
- chronic kidney disease
- mechanical ventilation
- prognostic factors
- photodynamic therapy
- peritoneal dialysis
- intensive care unit
- patient reported outcomes
- case control